Back to All Studies

In humans, a powerful immunologic reagent called a tetramer is standardly used to visualize changes in the body's killer T-cells. These cells respond to immunologic challenges and are critical to the body's immune system. Current knowledge of T-cell behavior in dogs could be significantly advanced with the development of a dog-specific tetramer. Researchers will work to construct the first canine tetramer, which would then be used in the development of vaccines for infectious diseases and cancer in dogs.

Study ID
D15CA-015
Study Status
Complete
Start Date
09/01/2014
Grant amount awarded
$45,887
Grant recipient
North Carolina State University
Study country
United States
Investigator
Paul R. Hess, DVM, PhD
Study category
Immunology